(Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 143.56%61.14K | 77.28%-38.33K | 137.29%112.76K | 38.31%-519.82K | 1.07%91.63K | 62.58%-140.36K | -6.36%-168.69K | 24.34%-302.41K | -7.30%-842.67K | 134.45%90.66K |
Net income from continuing operations | 66.81%-153.85K | 62.74%-163.87K | 66.07%-191.87K | -459.92%-3.97M | -323.85%-2.5M | 23.31%-463.54K | -120.60%-439.81K | 65.72%-565.42K | 56.06%-709.31K | 13.43%-590.48K |
Operating gains losses | -111.88%-38.42K | -98.65%20.66K | 97.98%-7.01K | 7.47%-650.6K | -263.38%-2.16M | 328.74%323.36K | 1,055.59%1.53M | -1,262.70%-347.22K | -484.64%-703.1K | -665.78%-593.09K |
Depreciation and amortization | -30.06%754 | -30.03%755 | -29.96%755 | -29.98%4.31K | -29.94%1.08K | -30.00%1.08K | -29.98%1.08K | -30.00%1.08K | -30.01%6.16K | -30.03%1.54K |
Asset impairment expenditure | ---- | ---- | ---- | --2.1M | ---- | ---- | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | 156.03%35.21K | 96.89%-42.22K | -97.88%17.45K | 258.85%1.58M | 148.79%2.18M | -121.39%-62.84K | 38.28%-1.36M | -44.07%822.67K | 7.85%439.94K | 108.51%874.78K |
Remuneration paid in stock | --0 | ---- | ---- | 65.94%117.61K | 65.94%117.61K | --0 | ---- | ---- | -60.90%70.88K | --70.88K |
Change In working capital | 253.06%217.45K | 47.63%146.34K | 237.43%293.45K | 472.88%302.21K | 8.56%355.01K | 143.58%61.59K | 53.95%99.13K | -8.21%-213.52K | -84.98%52.75K | 338.23%327.03K |
-Change in receivables | 96.45%-283 | -283.75%-27.61K | 1,178.91%86.78K | -1,587.17%-35.01K | -138.95%-11.79K | -8.94%-7.98K | 82.38%-7.19K | -139.73%-8.04K | -98.96%2.35K | -84.21%30.27K |
-Change in prepaid assets | 45.92%-21.45K | ---- | ---- | ---- | ---- | -4.04%-39.66K | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | 118.97%239.18K | 40.79%138.48K | 200.58%206.67K | 569.10%337.22K | 8.24%335.11K | 213.91%109.23K | 81.30%98.36K | 5.56%-205.48K | -59.51%50.4K | 1,168.68%309.61K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 143.56%61.14K | 77.28%-38.33K | 137.29%112.76K | 38.31%-519.82K | 1.07%91.63K | 62.58%-140.36K | -6.36%-168.69K | 24.34%-302.41K | -7.30%-842.67K | 134.45%90.66K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -130.18%-55.46K | -10.39%36.62K | -140.96%-144.78K | 236.58%524.77K | -395.00%-53.34K | -45.13%183.77K | 114.70%40.86K | 182.10%353.47K | 86.53%-384.23K | -104.06%-10.78K |
Net PPE purchase and sale | 80.13%-55.45K | 73.86%-112.63K | 36.71%-199.79K | 25.98%-1.28M | 36.94%-259.24K | -67.39%-279.11K | 33.30%-430.89K | 38.33%-315.67K | 1.37%-1.74M | -2,541.86%-411.09K |
Net investment purchase and sale | -100.00%-2 | -68.36%149.24K | -91.78%55.01K | 33.90%1.81M | -48.56%205.9K | -7.74%462.88K | 28.14%471.75K | 722.11%669.15K | 223.69%1.35M | 66.10%400.31K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -130.18%-55.46K | -10.39%36.62K | -140.96%-144.78K | 236.58%524.77K | -395.00%-53.34K | -45.13%183.77K | 114.70%40.86K | 182.10%353.47K | 86.53%-384.23K | -104.06%-10.78K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 0 | 0 | 8.34%-55K | 0 | -82.62%55K | 0 | 1.24M | -60K |
Net common stock issuance | --0 | --0 | --0 | --0 | 82.62%-55K | --0 | -81.74%55K | --0 | --984.66K | ---316.54K |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --256.54K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | --0 | --0 | 8.34%-55K | --0 | -82.62%55K | --0 | --1.24M | ---60K |
Net cash flow | ||||||||||
Beginning cash position | -32.16%14.82K | -82.54%16.53K | 11.34%48.55K | 48.72%43.61K | 175.11%65.26K | -65.78%21.84K | -48.49%94.67K | 48.72%43.61K | -99.20%29.32K | -11.99%23.72K |
Current changes in cash | -86.90%5.69K | 97.65%-1.71K | -162.71%-32.02K | -65.38%4.95K | -184.03%-16.71K | 208.25%43.42K | 39.29%-72.82K | -66.94%51.06K | 100.39%14.29K | 739.70%19.88K |
End cash Position | -68.58%20.51K | -32.16%14.82K | -82.54%16.53K | 11.34%48.55K | 11.34%48.55K | 175.11%65.26K | -65.78%21.84K | -48.49%94.67K | 48.72%43.61K | 48.72%43.61K |
Free cash from | 101.36%5.69K | 74.82%-150.96K | 85.92%-87.03K | 30.01%-1.8M | 47.69%-167.61K | 22.58%-419.46K | 25.49%-599.57K | 32.20%-618.08K | -1.31%-2.58M | -30.07%-320.43K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data